Trials / Recruiting
RecruitingNCT06385977
Risk Factors for Chronic Prostatitis Patients in Northwest China
Risk Factors for Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients in Northwest China
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Shaanxi Provincial People's Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to learn about the risk factors of lifestyle, medication and sexual habits in adult chronic prostatitis / chronic pelvic pain syndrome patients. The main questions it aims to answer are: * Is lifestyle, medication, and sexual habits related to chronic prostatitis / chronic pelvic pain syndrome * Is there any medication available to protect men from chronic prostatitis / chronic pelvic pain syndrome. Participants will: * Independently receive a survey questionnaire on lifestyle, medication, and sexual habits. * Symptomatic individuals will undergo additional prostate fluid examination for diagnosis. Researchers will compare healthy adult males to see if there are differences on lifestyle, medication and sexual habits between the two groups.
Detailed description
All participants were asked to fill out a questionnaire which was modified based on Zhang Ran's research. The questionnaire contained the following parts: patient's general situation, dietary habits, disease status, medication, lifestyle, sexual habits and NIH-CPSI index (National Institutes of Health Chronic Prostatitis Symptom Index). Furthermore, the patients underwent digital rectal examination, expressed prostatic secretion microscopy and microbial culture, urinalysis, urine microbial culture and transrectal ultrasonography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | lifestyle | Life habits and personal preferences |
| BEHAVIORAL | sexual habits | Sexual experience and activities |
| DRUG | medication | use of medication |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2024-06-30
- Completion
- 2024-07-01
- First posted
- 2024-04-26
- Last updated
- 2024-07-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06385977. Inclusion in this directory is not an endorsement.